BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

Core Insights - BioCardia, Inc. will provide a corporate update and report its financial results for the year ended December 31, 2025, on March 24, 2026, at 4:30 PM EDT [1] Company Overview - BioCardia, Inc. is headquartered in Sunnyvale, California, and focuses on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases [4] - The company’s biotherapeutic platforms include CardiAMP® autologous and CardiALLO™ allogeneic cell therapies, aimed at treating heart disease [4] - BioCardia utilizes its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms to enable these therapies [4] - The company also acts as a biotherapeutic delivery partner for therapies targeting heart failure, chronic myocardial ischemia, and acute myocardial infarction [4]